Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating levels of soluble Dipeptidylpeptidase-4 are reduced in human subjects hospitalized for severe COVID-19 infections
Kristina Schlicht, Nathalie Rohmann, Corinna Geisler, et al.
International Journal of Obesity (2020) Vol. 44, Iss. 11, pp. 2335-2338
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Daniel J. Drucker
Cell Metabolism (2021) Vol. 33, Iss. 3, pp. 479-498
Open Access | Times Cited: 239
Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury
Murat Öz, Dietrich E. Lorke
Biomedicine & Pharmacotherapy (2021) Vol. 136, pp. 111193-111193
Open Access | Times Cited: 52
Association Between Anti-diabetic Agents and Clinical Outcomes of COVID-19 in Patients with Diabetes: A Systematic Review and Meta-Analysis
Tiantian Han, Shaodi Ma, Chenyu Sun, et al.
Archives of Medical Research (2021) Vol. 53, Iss. 2, pp. 186-195
Open Access | Times Cited: 50
Impact of Sitagliptin on Non-diabetic Covid-19 Patients
Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Current Molecular Pharmacology (2021) Vol. 15, Iss. 4, pp. 683-692
Closed Access | Times Cited: 45
ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues
Sally Badawi, Bassam R. Ali
Human Genomics (2021) Vol. 15, Iss. 1
Open Access | Times Cited: 41
Role of genetic variants and host polymorphisms on COVID‐19: From viral entrance mechanisms to immunological reactions
Abolfazl Adli, Mandana Rahimi, Reza Khodaie, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1846-1865
Open Access | Times Cited: 36
Obesity and COVID-19: Mechanistic Insights From Adipose Tissue
Lili Yu, Xiaoying Zhang, Sarah Ye, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. 1799-1811
Open Access | Times Cited: 28
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, et al.
Future Virology (2023) Vol. 18, Iss. 5, pp. 321-333
Open Access | Times Cited: 20
DPP-4 inhibition and COVID-19: From initial concerns to recent expectations
André Scheen
Diabetes & Metabolism (2020) Vol. 47, Iss. 2, pp. 101213-101213
Open Access | Times Cited: 42
Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis
Rimesh Pal, Mainak Banerjee, Soham Mukherjee, et al.
Therapeutic Advances in Endocrinology and Metabolism (2021) Vol. 12
Open Access | Times Cited: 39
Dipeptidylpeptidase-4 levels and DPP4 gene polymorphisms in patients with COVID-19. Association with disease and with severity
Rosalinda Posadas‐Sánchez, Fausto Sánchez‐Muñoz, Carlos A. Guzmán-Martín, et al.
Life Sciences (2021) Vol. 276, pp. 119410-119410
Open Access | Times Cited: 34
DPP4 Inhibitors and COVID-19–Holy Grail or Another Dead End?
Alicja Krejner‐Bienias, Katarzyna Grzela, Tomasz Grzela
Archivum Immunologiae et Therapiae Experimentalis (2021) Vol. 69, Iss. 1
Open Access | Times Cited: 32
Insulin and Metformin Administration: Unravelling the Multifaceted Association with Mortality across Various Clinical Settings Considering Type 2 Diabetes Mellitus and COVID-19
Łukasz Lewandowski, Agnieszka Bronowicka-Szydełko, Maciej Rabczyński, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 605-605
Open Access | Times Cited: 4
Identification and validation of m6A RNA methylation and ferroptosis-related biomarkers in sepsis: transcriptome combined with single-cell RNA sequencing
Jinshuai Lu, Jianhao Wang, Kun Han, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
ACE2 function in the pancreatic islet: Implications for relationship between SARS‐CoV‐2 and diabetes
Bushra Memon, Essam M. Abdelalim
Acta Physiologica (2021) Vol. 233, Iss. 4
Open Access | Times Cited: 24
Optical genome mapping identifies rare structural variations as predisposition factors associated with severe COVID-19
Nikhil Sahajpal, Chi-Yu Jill Lai, Alex Hastie, et al.
iScience (2022) Vol. 25, Iss. 2, pp. 103760-103760
Open Access | Times Cited: 17
Decreased Circulating Dipeptidyl Peptidase-4 Enzyme Activity Is Prognostic for Severe Outcomes in Covid-19 Inpatients
Ákos Nádasdi, György Sinkovits, Ilona Bobek, et al.
Biomarkers in Medicine (2022) Vol. 16, Iss. 5, pp. 317-330
Open Access | Times Cited: 16
The dual role of toll-like receptors in COVID-19: Balancing protective immunity and immunopathogenesis
Payam Behzadi, Deepak Chandran, Chiranjib Chakraborty, et al.
International Journal of Biological Macromolecules (2024), pp. 137836-137836
Closed Access | Times Cited: 3
Dipeptidyl peptidase-4 (DPP-IV) inhibitor was associated with mortality reduction in COVID-19 — A systematic review and meta-analysis
Ahmad Fariz Malvi Zamzam Zein, Wilson Matthew Raffaello
Primary care diabetes (2021) Vol. 16, Iss. 1, pp. 162-167
Open Access | Times Cited: 21
Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection
Weronika Bielka, Agnieszka Przezak, Andrzej Pawlik
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7605-7605
Open Access | Times Cited: 20
The enzymes in COVID-19: A review
Maria Helena Menezes Estevam Alves, Layla Carvalho Mahnke, Tifany Cerqueira Macedo, et al.
Biochimie (2022) Vol. 197, pp. 38-48
Open Access | Times Cited: 13
Deciphering the Kidney Matrisome: Identification and Quantification of Renal Extracellular Matrix Proteins in Healthy Mice
Umut Rende, Seong Beom Ahn, Subash Adhikari, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2827-2827
Open Access | Times Cited: 7
Angiotensin-Converting Enzyme (ACE) level, but not ACE gene polymorphism, is associated with prognosis of COVID-19 infection: Implications for diabetes and hypertension
Onur Elbasan, Feyza Bayram, Ceyda Dinçer Yazan, et al.
PLoS ONE (2023) Vol. 18, Iss. 7, pp. e0288338-e0288338
Open Access | Times Cited: 7
Factors influencing on development of COVID-19 pneumonia and association with oral anti-diabetic drugs in hospitalized patients with diabetes mellitus
Ayça Elibol, Didem Eren, Macide Deniz Erdoğan, et al.
Primary care diabetes (2021) Vol. 15, Iss. 5, pp. 806-812
Open Access | Times Cited: 15
Changes in Adenosine Deaminase Activity and Endothelial Dysfunction after Mild Coronavirus Disease-2019
Agata Jędrzejewska, Ada Kawecka, Alicja Braczko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13140-13140
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top